Details of the Drug

General Information of Drug (ID: DMH3T2E)

• Drug Name: Triplex

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Phase 2	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D7RL1M

References

• [1] ClinicalTrials.gov (NCT05099965) Phase II, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex?), in Adults With Both Human Immunodeficiency Virus (HIV)-1 and CMV Who Are on Potent Combination ART With Conserved Immune Function. U.S.National Institutes of Health.